VF00102 / Vitrogro as a pain killer, page-6

Scary how this same scenario 'nobbled prana biotech ! ' Placebo group displayed similar (not same results) as the test group ……..FDA required more data from dogs of all things (AD drug was for humans & the drug was well tolerated at all stages so why dog data was required still puzzles me)…...but that was the end of the share price and it has languished ever since. Even good announcements have little or no effect on the SP now. So good luck.....but financial life on the 'dark side' in biotechland is not nice. Capital raisings, dilution and possible liquidation all will most likely arrive. SO decide to either take a loss & enjoy closure, move on...or cling on for the unlikely rebound. I feel for you guys ! I've been there and done that.